NEJM Interview: Dr. Roy Perlis on esketamine as an option for treatment-resistant depression. - a podcast by The New England Journal of Medicine

Dr. Roy Perlis is the director of the Center for Quantitative Health at Massachusetts General Hospital and a professor of psychiatry at Harvard Medical School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J. Kim and Others. Esketamine for Treatment-Resistant Depression — First FDA-Approved Antidepressant in a New Class. N Engl J Med 2019;381:1-4.

Further episodes of 301 Moved Permanently

Further podcasts by The New England Journal of Medicine

Website of The New England Journal of Medicine